Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774718
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2021-02-10
Brief Title:
A Study Evaluating the Safety Pharmacokinetics and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-03
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-10
First Submit QC Date:
February 25 2021
Study First Post Date:
2021-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED